The new 23andMe genetic testing kit doesn't focus on discovering lineage, instead, it allows users to find out which drugs might work best for them. This new form of genetic testing recently received FDA approval and will tell consumers about 33 genetic variants that are associated with common drugs. The 23andMe genetic testing kit is still fairly reserved and will not overpromise what it can do and is adamant that users should not change their medication based on the results they get from these kits.
The release of this kit is a big step forward in making genetic variant information available for consumers and works as a tool to better inform users of the drugs that might be better for their systems. While the system is not perfect, the 23andMe genetic testing kit indicates a huge step forward in pharmacogenetics.
Image Credit: 23andMe
Why This Trend Is Growing
- Pharmacogenetics Testing Kits
- Drug companies and genetic testing companies can work together to develop more personalized and effective drug treatments based on an individual's genetic information.
- Consumer Empowerment in Healthcare
- With access to their genetic information, consumers can be more informed and take an active role in their healthcare and treatment plans.
- Medical Data Privacy Regulations
- As consumers become more reliant on genetic testing data, there may be a greater need for stricter privacy regulations to protect this sensitive health information.
Industries Being Reshaped
- Pharmaceuticals
- Drug companies can use genetic testing information to develop more targeted and effective medications.
- Genetic Testing
- Genetic testing companies can expand their offerings to include pharmacogenetic testing and provide consumers with more comprehensive genetic information.
- Healthcare Technology
- Technological advancements in genetic testing and data analysis can lead to more efficient and accurate personalized medicine.
